Genelux (GNLX) Research & Development (2022 - 2026)

Genelux's Research & Development history runs 5 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• In Q1 2026, Research & Development rose 22.99% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $20.9 million (up 6.32% YoY), while the FY2025 annual figure was $19.9 million, up 4.49% from the prior year.
• Research & Development was $5.8 million for Q1 2026 at Genelux, up from $5.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.5 million in Q4 2024 to a low of $2.4 million in Q3 2022.
• Historically, Research & Development has averaged $4.2 million across 5 years, with a median of $4.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Research & Development surged 68.56% in 2023, then retreated 13.28% in 2025.
• A 5-year view of Research & Development shows it stood at $2.5 million in 2022, then soared by 68.56% to $4.2 million in 2023, then soared by 56.73% to $6.5 million in 2024, then declined by 13.28% to $5.7 million in 2025, then gained by 2.19% to $5.8 million in 2026.
• The last three Research & Development figures came in at $5.8 million (Q1 2026), $5.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.